Nasdaq biol.

Spare a thought for those who held BIOLASE, Inc. (NASDAQ:BIOL) for five whole years - as the share price tanked 88%. Shareholders have had an even rougher run lately, with the share price down 46% ...The company's shares jumped 32.6% to $3.46 in premarket trading. Tracon pharmaceuticals, inc.'s shares surged 116.9% after reporting better- than-expected sales. BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists ...Fiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest BIOLASE Inc (BIOL) real-time quote, historical performance, charts, and other financial information to help …BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its ...BIOL. The Nasdaq Stock Market LLC. (Nasdaq Capital Market). Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 ...

(NASDAQ: BIOL), the global leader in dental lasers, announced today that due to the growing adoption of its market leading laser technology, BIOLASE has taken the innovative step of creating a ...Source: Kantar Media. Advertisement. Biolase Inc. analyst ratings, historical stock prices, earnings estimates & actuals. BIOL updated stock price target summary.Feb 10, 2021 · FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering ...

LAKE FOREST, Calif., June 5, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that its Board of Directors declared ...

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the third quarter ended September 30,...BIOLASE Inc (NASDAQ: BIOL) has announced to sell 14 million common shares at $1.03 per share, raising $14.4 million in gross proceeds. The offering price represents a discount of 15% from the last ...FOOTHILL RANCH, Calif., April 20, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products ...FOOTHILL RANCH, Calif., May 13, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for its first quarter ended March 31, 2021.

Jan 18, 2023 · BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that based on currently available information, preliminary 2022 fourth quarter revenue is expected to be between ...

Hedge fund interest in ENGlobal Corp (NASDAQ: ENG) shares was flat at the end of last quarter. This is usually a negative indicator. Our calculations also showed that ENG isn't among the 30 most ...

Jan 18, 2023 · BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that based on currently available information, preliminary 2022 fourth quarter revenue is expected to be between ... Nelly Dodson. December 4, 2023. Technologies. Biolase Inc (NASDAQ:BIOL) has a beta value of 1.20 and has seen 1.07 million shares traded in the recent trading session. The company, currently valued at $3.29M, closed the recent trade at $1.43 per share which meant it gained $0.28 on the day or 24.35% during that session.Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific ...BIOLASE's CEO is John Beaver, appointed in Feb 2021, has a tenure of 2.75 years. total yearly compensation is $733.09K, comprised of 51.2% salary and 48.8% bonuses, including company stock and options. directly owns 0.005% of the company’s shares, worth $152.65. The average tenure of the management team and the board of directors is 2 years ...8 Nov 2023 ... Biolase (NASDAQ:BIOL) shares are rising more than 24% with the release of positive study results. Upwork (NASDAQ:UPWK) stock is heading over ...How are hedge funds trading Biolase Inc (NASDAQ:BIOL)? Heading into the fourth quarter of 2020, a total of 4 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 33 ...Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable ...

To maintain listing, the Nasdaq Capital Market requires, among other things, that our common stock maintain a minimum closing bid price of $1.00 per share. On May 24, 2021, we received a deficiency letter from the Nasdaq Stock Market notifying us that, for the 30 consecutive business days ended May 21, 2021, the bid price for our common stock ...Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.What is BIOLASE's consensus rating and price target? According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is …Feb 10, 2022 · The image below, which you can click on for greater detail, shows that BIOLASE had debt of US$13.5m at the end of September 2021, a reduction from US$16.1m over a year. But it also has US$33.4m in ... BIOL Biolase Inc Form 8-K - Current report BIOLASE, INC false 0000811240 0000811240 2023-11-14 2023-11-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K ...BIOLASE (NASDAQ:BIOL – Get Free Report) last posted its earnings results on Thursday, August 10th. The medical technology company reported ($8.93) earnings per share (EPS) for the quarter.Biolase Inc (NASDAQ:BIOL) trade information. Instantly BIOL has been showing a green trend so far today with a performance of 5.70% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.7500 on Tuesday, 11/07/23 increased the stock’s daily price by 4.57%.

BIOLASE, Inc. 17 Nov, 2021, 16:05 ET. FOOTHILL RANCH, Calif., Nov. 17, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, encourages stockholders to vote TODAY ...BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, …

BIOLASE, Inc. (NASDAQ:BIOL) Q4 2022 Earnings Call Transcript (Insider Monkey)-7.63%. Mar-28-23 04:16PM Biolase: Q4 Earnings Snapshot (AP Finance) 04:05PM Biolase Inc BIOL Morningstar Rating Unlock Stock XNAS Rating as of Dec 1, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials …BIOL Biolase Inc BIOLASE, Inc to Report First Quarter 2022 Results on May 12, 2022Sep 13, 2021 · Biolase (NASDAQ: BIOL) TransGlobeEnergy (NASDAQ: TGA) Best Penny Stocks: ConforMIS (CFMS) Source: Shutterstock. Penny stocks are usually niche players. Their road to riches lies in either a better ... FOOTHILL RANCH, Calif., Jan. 25, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser company, today released the following statement in response to the attempt by ...BIOLASE Inc stock price (BIOL). NASDAQ: BIOL. Buying or selling a stock that's not traded in your local currency? Don't let the currency conversion trip you ...

BIOLASE Inc stock price (BIOL). NASDAQ: BIOL. Buying or selling a stock that's not traded in your local currency? Don't let the currency conversion trip you ...

The Nasdaq Capital Market requires, among other things, that a listing a company's common stock maintain a minimum bid price of at least $1.00 per share. Information for BIOLASE Stockholders

FOOTHILL RANCH, Calif., Aug. 31, 2021 /PRNewswire/ -- Today BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced a clinical advisory partnership with Dr. L. Stephen Buchanan ...17 Dec, 2020, 09:00 ET. IRVINE, Calif., Dec. 17, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced a collaboration with BMW Performance Center ...BIOL Biolase Inc Statement of Ownership (sc 13g) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction ...Research BIOLASE's (Nasdaq:BIOL) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Dashboard Markets Discover Watchlist Portfolios ScreenerGainers Tian Ruixiang Holdings Ltd (NASDAQ: TIRX) shares jumped 537.5% to close at $25.50 on Wednesday after the company priced its IPO at $4 per share.BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of ...LAKE FOREST, Calif., Sept. 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 75,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series J Convertible Redeemable …BIOL. The Nasdaq Stock Market LLC. (Nasdaq Capital Market). Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 ...You can click the graphic below for the historical numbers, but it shows that BIOLASE had US$13.1m of debt in June 2021, down from US$16.7m, one year before. However, its balance sheet shows it ...Apr 28, 2022 · The Nasdaq Capital Market requires, among other things, that a listing a company's common stock maintain a minimum bid price of at least $1.00 per share. Information for BIOLASE Stockholders Biolase (NASDAQ: BIOL) stock is taking a beating on Friday following the release of its earnings report for the first quarter of 2023. The bad news for investors in BIOL stock is the company’s ...

28 Feb, 2019, 08:00 ET. IRVINE, Calif., Feb. 28, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, announced the appointment of Sinclair Dental Co. Ltd, the ...BIOL Edit my quotes Biolase, Inc. Common Stock (BIOL) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Key Data Bid Price and Ask Price The bid & ask refers to the price... Find the latest on short interest for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.The 36-month beta value for BIOL is also noteworthy at 1.33. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”. The average price estimated by analysts for BIOL is $16.33, which is $14.66 above than the current price.Instagram:https://instagram. eye insurance ncnew apartment buildingsnasdaq dltr comparesilverbow These institutions hold a total of 1 shares. Largest shareholders include Huntington National Bank . Biolase Inc (NASDAQ:BIOL) institutional ownership structure ... best credit card for capital onetop 10 wealth management companies BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, … nyse o Dec 1, 2023 · The firm earned $10.92 million during the quarter. BIOLASE has generated ($158.82) earnings per share over the last year ( ($158.82) diluted earnings per share). BIOLASE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off prior year's report dates. The image below, which you can click on for greater detail, shows that BIOLASE had debt of US$13.5m at the end of September 2021, a reduction from US$16.1m over a year. But it also has US$33.4m in ...